Comparative studies of LFA-1/ICAM-1 interaction by micropipette and flow chamber techniques

Hong Zhao1, Fengyuan Zhuang, Jean François Stoltz

  • 1Cell and Tissue Engineering and Mechanics, LEMTA-UMR 7563 CNRS and IFR111 Bioengineering, Faculté de Médecine, 54500, Vandoeuvre-lès-Nancy, France.

Biorheology
|November 28, 2002
PubMed

Insights

Phytohemagglutinin (PHA) increases lymphocyte adhesion via LFA-1 and ICAM-1 interactions. Tetramethylpyrazine (TMP) significantly inhibits this adhesion, offering potential therapeutic insights for inflammatory conditions.

Area of Science:

  • Immunology
  • Cell Biology
  • Biophysics

Background:

  • Lymphocyte function-associated antigen-1 (LFA-1) and intercellular adhesive molecule-1 (ICAM-1) mediate crucial cellular interactions.
  • These interactions are vital for inflammation, cell adhesion, and transendothelial migration.

Purpose of the Study:

  • To comparatively analyze LFA-1/ICAM-1 adhesive interactions using micropipette and flow chamber methods.
  • To investigate the modulatory effects of tumor necrosis factor-alpha (TNF-alpha), phytohemagglutinin (PHA), and tetramethylpyrazine (TMP) on LFA-1/ICAM-1 adhesion.

Main Methods:

  • Micropipette technique to measure adhesion probability (Pa) between SKW-3 cells (expressing LFA-1) and ICAM-1-coated red blood cells (RBCs).
  • Flow chamber method to assess firm adhesion of SKW-3 cells onto human umbilical vein endothelial cells (HUVECs).

Main Results:

  • Phytohemagglutinin (PHA) significantly increased lymphocyte adhesion probability (Pa) and firm adhesion to HUVECs.
  • Tetramethylpyrazine (TMP) demonstrated significant inhibitory effects on PHA-induced increases in lymphocyte adhesion.

Conclusions:

  • PHA enhances lymphocyte adhesion through LFA-1/ICAM-1 pathways.
  • TMP can effectively suppress LFA-1/ICAM-1 mediated lymphocyte adhesion, suggesting potential anti-inflammatory applications.

Related Concept Videos